Subject matters | Details | Categories |
---|---|---|
Health, Research and Development, Science and Technology
|
Canadian Institutes of Health Research (CIHR) and the Strategy for Patient-Orientated Research (SPOR)
Discussions with CIHR and SPOR Network about collaboration towards the creation of a type 1 diabètes registry
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|
Health
|
Ensuring Bill C-64, the National Pharmacare Act, meets the needs of Canadians living with type 1 diabetes by having adequate insulin and diabetes devices coverage, while respecting patient choice.
|
Legislative Proposal, Bill or Resolution, Policies or Program, Grant, Contribution or Other Financial Benefit
|
Health, Research and Development, Science and Technology
|
Meeting with Juvenile Diabetes Caucus Co-Chairs to discuss strategies and tactics to move JDRF Canada Pre-Budget Submission priorities forward including additional funding for research towards a cure for type 1 diabetes
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|
Health, Research and Development, Science and Technology
|
Ongoing conversation with Health Minister's Office regarding JDRF-CIHR Partnership to Defeat Diabetes renewal funding.
|
Grant, Contribution or Other Financial Benefit
|
Health, Research and Development, Science and Technology
|
Seek an increase funding for the Canadian Clinical Trial Network to find a cure for Type 1 Diabetes (T1D).
|
Grant, Contribution or Other Financial Benefit, Policies or Program
|
Health, Research and Development, Science and Technology
|
Seek increased funding for type 1 diabetes research
|
Grant, Contribution or Other Financial Benefit
|
Education, Health
|
To seek funding to expand the foundation's educational program to raise awarenes of type 1 diabetes and diabetes management in Canada.
|
Grant, Contribution or Other Financial Benefit
|
Health Research Charity
Jessica Diniz, President and Chief Executive Officer
Address:
235 Yorkland Blvd, Suite 600
Toronto, ON M2J 4Y7
Canada
Telephone number:
647-789-2021